Loading data
RXRXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 74.68 m USD | 58.84 m USD | 44.58 m USD | 39.84 m USD | 10.18 m USD |
| Cost of revenue | 70.95 m USD | 45.24 m USD | 42.59 m USD | 48.28 m USD | 0 USD |
| Research and development expense | 475.27 m USD | 314.42 m USD | 241.23 m USD | 155.7 m USD | 135.27 m USD |
| Operating profit | -648.13 m USD | -479 m USD | -350.06 m USD | -245.73 m USD | -182.78 m USD |
| Interest expense | — | — | 97 k USD | 55 k USD | 2.95 m USD |
| Profit before tax | -644.9 m USD | -464.79 m USD | -332.13 m USD | -239.48 m USD | -186.48 m USD |
| Income tax expense | -136 k USD | -1.13 m USD | -4.06 m USD | 0 USD | 0 USD |
| Net income (reported basis) | -644.76 m USD | -463.66 m USD | -328.07 m USD | -239.48 m USD | -186.48 m USD |
| Basic earnings per share | -1.44 USD/share | -1.69 USD/share | -1.58 USD/share | -1.36 USD/share | -1.49 USD/share |
| Diluted earnings per share | -1.44 USD/share | -1.69 USD/share | -1.58 USD/share | -1.36 USD/share | -1.49 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.